Quipt Home Medical (QIPT) AI Stock Analysis

• Market Cap: C$217.50M
• Dividend Yield: N/A
• Average Volume (3M): 16.89K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.60
• Revenue Growth: 2.48%
• EPS Growth: -53.76%
• Country: CA
• Employees: 1,200
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): -0.11
• Shares Outstanding: 44,027,473
• 10 Day Avg. Volume: 16,042
• 30 Day Avg. Volume: 16,885
• PEG Ratio: -0.12
• Price to Book (P/B): 1.12
• Price to Sales (P/S): 0.46
• P/FCF Ratio: 4.44
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: C$5.24
• Price Target Upside: 6.12% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 3
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 70 Outperform
• Price Target: C$5.50 ▲(11.34% Upside)

Quipt Home Medical's overall score is driven by strong technical momentum and strategic expansions, despite profitability challenges and valuation concerns. The company's ability to generate cash and strategic partnerships provide a positive outlook, but improvements in profitability are necessary for long-term growth.

Positive Factors

Strategic Partnerships

These partnerships expand Quipt's presence into Michigan and Ohio, enhancing market reach and providing a competitive edge in the healthcare sector.

Cash Flow Generation

Strong cash flow growth indicates effective cash generation, supporting operational needs and strategic investments, crucial for long-term sustainability.

Recurring Revenue

A high percentage of recurring revenue ensures a stable income stream, enhancing financial predictability and reducing reliance on new sales.

Negative Factors

Profitability Challenges

Negative profitability metrics indicate struggles in cost management and revenue efficiency, which could hinder long-term financial health.

Revenue Decline

Year-over-year revenue decline suggests potential market challenges or competitive pressures, impacting growth prospects if not addressed.

Increased Operating Expenses

Rising operating expenses can erode margins and profitability, necessitating improved cost control measures to sustain financial performance.

Quipt Home Medical Business Overview & Revenue Model

Company Description

Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company also provides bariatric equipment, bathroom safety products, bilevel positive airway pressure, canes/crutches, continuous positive airway pressure, CPAP masks and accessories, hospital beds, humidifiers, nebulizers and compressors, oxygen concentrators, patient lifts, walkers, wheelchairs, and products for wound care. In addition, it offers ventilators; home-based sleep apnea and chronic obstructive pulmonary disease treatments; home-based healthcare logistics and services; medical supplies, medical equipment, mobility equipment, and respiratory equipment; and CPAP and BiPAP units, ventilation equipment and aids, daily and ambulatory aides, and equipment solutions, as well as home and hospital delivery, and oxygen therapy services. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.

How the Company Makes Money

Quipt Home Medical generates revenue through multiple streams, primarily by providing durable medical equipment and related services to patients with chronic health conditions. The company earns money from the sale and rental of medical equipment, such as oxygen concentrators, CPAP machines, and mobility aids. Additionally, Quipt receives reimbursements from government programs like Medicare and Medicaid, as well as private insurance providers, for the medical equipment and services it supplies. Strategic partnerships with healthcare providers and institutions enhance its reach, while a focus on patient-centric services ensures a steady demand for its offerings.

Quipt Home Medical Financial Statement Overview

Summary

Quipt Home Medical shows strong revenue growth, but faces profitability challenges with negative net income and EBIT margins. The balance sheet is stable but increasing leverage could pose risks. Cash flow is strong, indicating good cash generation, but profitability improvements are needed.

Income Statement

Quipt Home Medical has demonstrated strong revenue growth, with a 49.38% increase in the latest year, indicating a robust expansion trajectory. However, the company is facing profitability challenges, as evidenced by negative net income and EBIT margins. The gross profit margin remains healthy, suggesting efficient cost management at the production level, but the negative net profit margin highlights issues in controlling operating expenses or other costs.

Balance Sheet

The balance sheet shows a moderate debt-to-equity ratio, indicating a balanced approach to leveraging. However, the return on equity is negative, reflecting the company's struggle to generate profit from shareholders' equity. The equity ratio is stable, suggesting a solid asset base relative to equity, but the increase in total debt over the years could pose a risk if not managed carefully.

Cash Flow

Cash flow analysis reveals a strong growth in free cash flow, up by 71.48%, which is a positive indicator of the company's ability to generate cash. The operating cash flow to net income ratio is favorable, suggesting efficient cash generation relative to reported earnings. However, the reliance on free cash flow to cover net income indicates that profitability improvements are necessary for long-term sustainability.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	271.13M	343.09M	245.91M	211.68M	139.86M	102.35M
Gross Profit	177.18M	177.18M	176.99M	153.78M	106.65M	74.18M
EBITDA	51.30M	48.32M	51.07M	45.14M	28.05M	10.45M
Net Income	-10.70M	-10.70M	-6.76M	-2.78M	4.84M	-6.17M
Balance Sheet
Total Assets	425.45M	425.45M	247.25M	247.41M	132.21M	108.57M
Cash, Cash Equivalents and Short-Term Investments	17.97M	17.97M	16.17M	17.21M	8.52M	34.61M
Total Debt	118.79M	118.79M	99.80M	97.96M	26.56M	27.05M
Total Liabilities	269.48M	269.48M	140.06M	136.29M	52.67M	49.95M
Stockholders Equity	139.69M	139.69M	107.19M	111.11M	79.55M	58.62M
Cash Flow
Free Cash Flow	28.47M	35.43M	25.07M	33.75M	17.38M	13.65M
Operating Cash Flow	41.53M	52.71M	35.38M	40.54M	26.34M	18.69M
Investing Cash Flow	-42.22M	-46.07M	-10.31M	-82.83M	-42.49M	-17.84M
Financing Cash Flow	-1.64M	-10.85M	-26.15M	50.87M	-9.85M	3.91M

Quipt Home Medical Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 4.94
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:QIPT, the sentiment is Positive. The current price of 4.94 is above the 20-day moving average (MA) of 4.58, above the 50-day MA of 3.81, and above the 200-day MA of 3.24, indicating a bullish trend. The MACD of 0.35 indicates Positive momentum. The RSI at 85.47 is Negative, neither overbought nor oversold. The STOCH value of 89.83 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:QIPT.

Quipt Home Medical Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
QIPT	70 Outperform	C$217.50M	-14.31	-10.51%	―	2.48%	-53.76%
PRN	55 Neutral	C$427.52M	-6.31	-127.60%	―	72.03%	-1.47%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
VPT	50 Neutral	C$20.96M	-5.04	―	―	28.59%	23.46%
PINK	46 Neutral	C$31.91M	-1.43	-181.70%	―	209.29%	35.38%
TLT	46 Neutral	C$50.13M	-11.14	-269.41%	―	1.46%	6.91%
BLO	46 Neutral	C$73.86M	-11.30	-188.03%	―	―	-52.41%